HCV Treatment in Liver Transplantation: Changes in Center Attitudes and Practices in the DAA Era

被引：0
|
作者：
Shaffer, Ashton [1 ]
Cash, Ayla [1 ]
Anjum, Saad [1 ]
Gurakar, Ahmet [1 ]
Durand, Christine [1 ]
Segev, Dorry [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P-133
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [31] Incidence and Determinants of Denial of DAA Treatment for Chronic HCV Infection by Insurance Type During the First 6 Months of the Modern HCV Treatment Era
    Lo Re, Vincent
    Gowda, Charitha
    Urick, Paul N.
    Halladay, Josh
    Binkley, Amanda
    Carbonari, Dena M.
    Battista, Kathryn
    Peleckis, Cassandra
    Gilmore, Jody
    Roy, Jason
    Reddy, K. Rajender
    Kostman, Jay
    HEPATOLOGY, 2015, 62 (06) : 1382A - 1382A
  • [32] Influence of DAA treatment on waitlisting and transplant rate (TR) for HCV related liver disease: preliminary results of a single center experience.
    Iegri, Claudia
    Pasulo, Luisa
    Baldan, Anna
    Colledan, Michele
    Luca, Maria Grazia
    Pinelli, Domenico
    Sangiovanni, Laura
    Ghilardi, Arianna
    Fagiuoli, Stefano
    HEPATOLOGY, 2017, 66 : 878A - 878A
  • [33] INFLUENCE OF DAA TREATMENT ON WAITLISTING AND TRANSPLANT RATE (TR) FOR HCV-RELATED LIVER DISEASE: PRELIMINARY RESULTS OF A SINGLE CENTER EXPERIENCE
    Iegri, Claudia
    Pasulo, Luisa
    Baldan, Anna
    Colledan, Michele
    Luca, Maria Grazia
    Pinelli, Domenico
    Ghirardi, Arianna
    Fagiuoli, Stefano
    TRANSPLANT INTERNATIONAL, 2017, 30 : 233 - 233
  • [34] Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
    Seo, Kwang Il
    Yun, Byung Chul
    Li, Weiquan James
    Lee, Sang Uk
    Han, Byung Hoon
    Park, Eun Taek
    CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (01) : 74 - 79
  • [35] Decline in HCV as an etiology for liver transplantation in direct acting antivirals era
    Choudhary, N. S.
    Saraf, N.
    Saigal, S.
    Rastogi, A.
    Bhangui, P.
    Thiagrajan, S.
    Vohra, V. K.
    Soin, A. S.
    TRANSPLANTATION, 2019, 103 (08) : 397 - 397
  • [36] REDUCTION IN RACIAL/ETHNIC DISPARITIES FOR LIVER TRANSPLANTATION IN AFRICAN AMERICANS WITH HCC DURING THE DAA ERA
    Shaikh, Anjiya T.
    Goli, Karthik
    Lymberopoulos, Peter
    Allam, Anthony Kaspa R.
    Benhammou, Jihane N.
    Lee, Tzu-Hao
    Rich, Nicole E.
    Goss, John A.
    Ahmed, Aijaz
    Rana, Abbas
    Kanwal, Fasiha
    Cholankeril, George T.
    GASTROENTEROLOGY, 2022, 162 (07) : S1290 - S1290
  • [37] DAA-Containing Regimens for the Treatment of Recurrent HCV Infection After Liver Transplantation Are Safe and Effective Regardless of Genotype and Fibrosis Stage
    Brahmbhatt, Rinjal
    Rudloff, Robyn
    McCashland, Timothy
    GASTROENTEROLOGY, 2015, 148 (04) : S1053 - S1053
  • [38] HCV Eradication with DAA Therapy Should Be Attempted Prior to Liver Transplantation and Does Not Impact HCC Recurrence
    Emamaullee, J.
    Bral, M.
    Meeberg, G.
    Montano-Loza, A.
    Bain, V.
    Bigam, D.
    Kneteman, N.
    Shapiro, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 784 - 785
  • [39] Cost and effectiveness of hepatitis C virus cryoglobulinemia vasculitis (HCV-CryoVas) treatment in the era of direct acting antivirals (DAA) in a tertiary French center
    Cacoub, Patrice P.
    Vautier, Mathieu
    Desbois, Anne Claire
    Doz, Marianne
    Lafuma, Antoine
    HEPATOLOGY, 2016, 64 : 402A - 402A
  • [40] Single center experience in HCC recurrence with DAA treatment in liver transplant recipients
    Mahboub, P.
    Movahedi, B.
    Ahern, A.
    Martins, P.
    Bozorgzadeh, A.
    TRANSPLANTATION, 2018, 102 : 114 - 115
12345